A hypocitraturia jelentösége kalcium oxalát okozta veseköbetegségben.

Translated title of the contribution: The significance of hypocitruria in calcium oxalate induced nephrolithiasis

C. Horváth, J. Németh, B. Büki, P. Vargha

Research output: Contribution to journalArticle

Abstract

The citrate concentration of the daily collected urine was measured by citrate lyase method in 25 untreated patients with recurrent calcium stone disease (10 hypercalciuric and 15 normocalciuric) and in 11 patients with stone disease treated with hydrochlorothiazide and in 16 healthy controls. We found a great variancy of the results what rather looks like biological than methodic type. The concentration (1.99 +/- 1.33 mmol/l in normocalciuric and 2.77 +/- 1.62 in hypercalciuric stone formers but 5.06 +/- 2.81 in controls) and the daily output of the urinary citrate (2.74 +/- 1.38 mmol/d and 4.24 +/- 1.69 vs. 4.41 +/- 1.85) but not the citrate/creatinine ratio was significantly less in about the half of stone formers. The hypocitraturia was frequent in the normocalciuric and very rare in the hypercalciuric group of the renal stone patients. Measurement of the urine citrate concentration is more sensitive tool in the diagnosis of hypocitraturic state than daily citrate output while the latter is more characteristic for the patient, so common study of the two parameters is recommended.

Original languageHungarian
Pages (from-to)2475-2478
Number of pages4
JournalOrvosi Hetilap
Volume131
Issue number45
Publication statusPublished - Nov 11 1990

Fingerprint

Citric Acid
citrate (pro-3S)-lyase
Urine
Hydrochlorothiazide
Creatinine
Calcium Oxalate Nephrolithiasis
Calcium
Kidney

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A hypocitraturia jelentösége kalcium oxalát okozta veseköbetegségben. / Horváth, C.; Németh, J.; Büki, B.; Vargha, P.

In: Orvosi Hetilap, Vol. 131, No. 45, 11.11.1990, p. 2475-2478.

Research output: Contribution to journalArticle

@article{30ee95b612064fa08eabd25124ccf5f5,
title = "A hypocitraturia jelent{\"o}s{\'e}ge kalcium oxal{\'a}t okozta vesek{\"o}betegs{\'e}gben.",
abstract = "The citrate concentration of the daily collected urine was measured by citrate lyase method in 25 untreated patients with recurrent calcium stone disease (10 hypercalciuric and 15 normocalciuric) and in 11 patients with stone disease treated with hydrochlorothiazide and in 16 healthy controls. We found a great variancy of the results what rather looks like biological than methodic type. The concentration (1.99 +/- 1.33 mmol/l in normocalciuric and 2.77 +/- 1.62 in hypercalciuric stone formers but 5.06 +/- 2.81 in controls) and the daily output of the urinary citrate (2.74 +/- 1.38 mmol/d and 4.24 +/- 1.69 vs. 4.41 +/- 1.85) but not the citrate/creatinine ratio was significantly less in about the half of stone formers. The hypocitraturia was frequent in the normocalciuric and very rare in the hypercalciuric group of the renal stone patients. Measurement of the urine citrate concentration is more sensitive tool in the diagnosis of hypocitraturic state than daily citrate output while the latter is more characteristic for the patient, so common study of the two parameters is recommended.",
author = "C. Horv{\'a}th and J. N{\'e}meth and B. B{\"u}ki and P. Vargha",
year = "1990",
month = "11",
day = "11",
language = "Hungarian",
volume = "131",
pages = "2475--2478",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "45",

}

TY - JOUR

T1 - A hypocitraturia jelentösége kalcium oxalát okozta veseköbetegségben.

AU - Horváth, C.

AU - Németh, J.

AU - Büki, B.

AU - Vargha, P.

PY - 1990/11/11

Y1 - 1990/11/11

N2 - The citrate concentration of the daily collected urine was measured by citrate lyase method in 25 untreated patients with recurrent calcium stone disease (10 hypercalciuric and 15 normocalciuric) and in 11 patients with stone disease treated with hydrochlorothiazide and in 16 healthy controls. We found a great variancy of the results what rather looks like biological than methodic type. The concentration (1.99 +/- 1.33 mmol/l in normocalciuric and 2.77 +/- 1.62 in hypercalciuric stone formers but 5.06 +/- 2.81 in controls) and the daily output of the urinary citrate (2.74 +/- 1.38 mmol/d and 4.24 +/- 1.69 vs. 4.41 +/- 1.85) but not the citrate/creatinine ratio was significantly less in about the half of stone formers. The hypocitraturia was frequent in the normocalciuric and very rare in the hypercalciuric group of the renal stone patients. Measurement of the urine citrate concentration is more sensitive tool in the diagnosis of hypocitraturic state than daily citrate output while the latter is more characteristic for the patient, so common study of the two parameters is recommended.

AB - The citrate concentration of the daily collected urine was measured by citrate lyase method in 25 untreated patients with recurrent calcium stone disease (10 hypercalciuric and 15 normocalciuric) and in 11 patients with stone disease treated with hydrochlorothiazide and in 16 healthy controls. We found a great variancy of the results what rather looks like biological than methodic type. The concentration (1.99 +/- 1.33 mmol/l in normocalciuric and 2.77 +/- 1.62 in hypercalciuric stone formers but 5.06 +/- 2.81 in controls) and the daily output of the urinary citrate (2.74 +/- 1.38 mmol/d and 4.24 +/- 1.69 vs. 4.41 +/- 1.85) but not the citrate/creatinine ratio was significantly less in about the half of stone formers. The hypocitraturia was frequent in the normocalciuric and very rare in the hypercalciuric group of the renal stone patients. Measurement of the urine citrate concentration is more sensitive tool in the diagnosis of hypocitraturic state than daily citrate output while the latter is more characteristic for the patient, so common study of the two parameters is recommended.

UR - http://www.scopus.com/inward/record.url?scp=0025705735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025705735&partnerID=8YFLogxK

M3 - Article

VL - 131

SP - 2475

EP - 2478

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 45

ER -